Quick Takeaways
- Steven Gillis has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,034,735.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Steven Gillis and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| VBIV | VBI Vaccines Inc/BC | Director | $1,726,075 | 27 Jul 2023 | ||
| QTTB | Homology Medicines, Inc. | Director | $308,660 | 14 Jun 2023 | ||
| CDAKQ | Codiak BioSciences, Inc. | Director | 16 Feb 2023 | |||
| SPTX | Seaport Therapeutics, Inc. | 10%+ Owner | 04 May 2026 | |||
| TAK, TKPHF | TAKEDA PHARMACEUTICAL CO LTD | Director | 18 Mar 2026 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|